Amylyx Pharmaceuticals
Healthcare
ALS Drug Relyvrio Withdrawn Due to Ineffectiveness
Amylyx Pharmaceuticals has decided to withdraw its ALS drug Relyvrio from the market following disappointing results from a phase III trial. The drug,...
